EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity

Lucia Brodosi, Michele Stecchi, Alessandra Musio, Matilde Bazzocchi, Eleonora Risi, Francesca Marchignoli, Giulio Marchesini, Maria Letizia Petroni

Acta Diabetologica · 29.04.2024 · 61 (8) · 1041-1051

DOI: 10.1007/s00592-024-02287-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Diabetologica, online erschienen am 29.04.2024. Verfasst von Lucia Brodosi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Depression, Anxiety, Severity of Illness Index. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione Cassa di Risparmio in Bologna, Associazione per la Ricerca ed Assistenza in Epatologia O.D.V., Alma Mater Studiorum - Università di Bologna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We aimed to evaluate the prevalence of anxiety and depression traits in Italian patients with metabolic dysfunction-associated steatotic liver disease (MASLD), and the possible relation with the severity of liver disease.

Methods

Demographic, anthropometric, clinical and laboratory parameters were collected in patients referred to a metabolic unit for a comprehensive evaluation of possible liver disease. Hepatic steatosis and fibrosis were evaluated by surrogate biomarkers. Imaging (controlled attenuation parameter-CAP and vibration-controlled transient elastography-VCTE). Beck depression inventory (BDI) and state-trait anxiety inventory-Y (STAI-Y) were used to define depressive/anxiety states; calorie intake and lifestyle were self-assessed by questionnaires.

Results

The whole sample comprised 286 patients (61.9% females; mean age 52.0 years; BMI, 34.6 kg/m 2 ); 223 fulfilled MASLD criteria. BDI and trait anxiety scores were lower in the MASLD cohort, and the prevalence of both moderate/severe depression and severe trait anxiety was reduced compared with non-MASLD cases, despite VCTE-diagnosed fibrosis F3–F4 present in over 15% of cases. However, after correction for demographic and anthropometric confounders, MASLD was not associated with a lower risk of moderate/severe depression or severe anxiety trait (odds ratio, 0.34; 95% confidence interval, 0.12–1.01 and 0.79, 0.27–2.34). Additional adjustment for the severity of fibrosis did not change the results. No differences in state anxiety were observed.

Conclusion

The risk of anxiety and depression in MASLD is not different from that generated by diabetes and obesity per se . MASLD patients do not perceive liver disease as a specific source of psychological distress, possibly as a consequence of the unawareness of progressive liver disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DepressionAnxietySeverity of Illness IndexHumansFemaleMaleMiddle AgedAdultItalyPrevalenceAgedFatty LiverCross-Sectional Studies

Stichwörter der Autor:innen

BiomarkersDistressImagingLiver fibrosisMetabolic dysfunction-associated steatotic liver diseaseNonalcoholic fatty liver diseaseVibration-controlled transient elastography

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
  • Clinical Nutrition and Metabolism Unit, IRCCS-Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy.
  • Alma Mater University, Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy. marialetizia.petroni@unibo.it.
  • Clinical Nutrition and Metabolism Unit, IRCCS-Azienda Ospedaliero-Universitaria Di Bologna, Bologna, Italy. marialetizia.petroni@unibo.it.

Förderung

  • Fondazione Cassa di Risparmio in Bologna
  • Associazione per la Ricerca ed Assistenza in Epatologia O.D.V.
  • Alma Mater Studiorum - Università di Bologna

Zitieren

APA

Brodosi, L., Stecchi, M., Musio, A., Bazzocchi, M., Risi, E., Marchignoli, F., Marchesini, G., & Petroni, M. L. (2024). Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity. Acta Diabetologica, 61(8), 1041-1051. https://doi.org/10.1007/s00592-024-02287-0

Vancouver

Brodosi L, Stecchi M, Musio A, Bazzocchi M, Risi E, Marchignoli F, et al. Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity. Acta Diabetologica. 2024;61(8):1041-1051. doi:10.1007/s00592-024-02287-0

BibTeX
@article{Brodosi2024,
  author = {Brodosi, Lucia and Stecchi, Michele and Musio, Alessandra and Bazzocchi, Matilde and Risi, Eleonora and Marchignoli, Francesca and Marchesini, Giulio and Petroni, Maria Letizia},
  title = {Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity},
  journal = {Acta Diabetologica},
  year = {2024},
  volume = {61},
  number = {8},
  pages = {1041--1051},
  doi = {10.1007/s00592-024-02287-0}
}
Kostenlos starten →